Fuda Cancer Hospital, Guangzhou: Liver Neoplasms trials
The registry lists 14 Liver Neoplasms studies with Fuda Cancer Hospital, Guangzhou as lead sponsor. 0 are open to participants now and 0 have results posted.
Phase 1 9Phase 2 11Phase 3 1No phase 3(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Liver CancerWithdrawnNCT03484962Phase 2
- PENS or TENS for Pain in Liver CancerCompletedNCT03338543Not applicable
- Bioinformation Therapy for Liver CancerCompletedNCT03239158Phase 2/3
- Safety and Efficiency of γδ T Cell Against Liver CancerCompletedNCT03183219Phase 1/2
- Combination of Cryosurgery and NK Immunotherapy for Tumors in Transplanted LiverCompletedNCT02849015Phase 1/2
- Combination of Cryosurgery and NK Immunotherapy for Advanced Liver CancerCompletedNCT02843802Phase 1/2
- Liver Cancer HepaSphere Combined With CryosurgeryCompletedNCT02545556Phase 1/2
- Nano Drug Interventional Therapy Using Digital Subtraction Angiography（DSA） for Liver CarcinomaCompletedNCT02449109Phase 1/2
- HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Liver CancerCompletedNCT02447263Phase 1/2
- Safety and Efficiency of γδ T Cell Against Hepatocellular Liver CancerCompletedNCT02425735Phase 1/2
- The Detection of Circulating Tumor Cells (CTCs) in Patients With Liver Cancer Undergoing Cryosurgery Combined With DC-CIK TreatmentCompletedNCT02416635
- Safety and Efficacy Study of Mix Vaccine in Hepatocyte Carcinoma PatientCompletedNCT02338778Phase 1/2
- Percutaneous Irreversible Electroportion in Unresectable Liver Cancer Close to Diaphragmatic DomeCompletedNCT02329106Not applicable
- Cancer Stem Cells Vaccine Therapy in Treating Hepatocellular Cancer PatientsCompletedNCT02089919Phase 1/2